Visit us at PODD 2024
Phillips Medisize is excited to attend the PODD conference, October 28-29th, 2024 and meet with leaders in the pharmaceutical industry. If you plan on attending, please stop by our table and say hello! We welcome the opportunity to discuss the latest in drug delivery devices and technology. Or, contact us if you’d like to set up time in advance.
Register today if you haven’t already!
Our very own Tony Bedford, Commercial Director of Platform Management & Innovation, will be presenting “The Evolution of Technology and Key Challenges Being Addressed in Diabetes Care” on October 29th at 10:35am in the main hall. Be sure to tune in!
Our Pharmaceutical Capabilities
From discovery to delivery, the world’s leading pharmaceutical companies select Phillips Medisize to help them engineer and manufacture their life-enhancing and lifesaving drug delivery devices. We leverage our 60 years of CDMO experience to design, develop and produce patient-centric devices, including autoinjectors, pen injectors, inhalers and ocular drug delivery systems, as well as on-body devices.
Our customers include 80% of the top 10 most valuable and strongest pharmaceutical companies.* In 2023, we helped our biopharma customers:
- Deliver more than 1.3 billion doses of lifesaving drug therapies
- Care for 25 million insulin-dependent patients
- Deliver more than 19 million emergency doses of lifesaving epinephrine
* https://brandirectory.com/rankings/pharma/
Phillips Medisize offers advanced manufacturing capabilities for drug delivery systems such as:
- Autoinjectors
- Pen injectors
- Inhalation devices
- Ocular drug delivery systems
- Wearable/on-body injection pumps and patches
- On-body injectors
- Novel devices
Ready to Develop Your Innovative Drug Delivery Device?
Contact us today!